With the analysis among 15,776 patents, we discovered top 439 key players by total patent application. Immatics Biotechnologies GmbH, Cellectis SA, Celgene Corp. are dominant in this area. They take 23.18% of the total patent filing.
Immatics Biotechnologies GmbH
Baden-Württemberg, Germany
Patent: 3,055
New Jersey, United States
Patent: 261
Washington, United States
Patent: 259
New Jersey, United States
Patent: 204
Colorado, United States
Patent: 168
The General Hospital Corp.
Massachusetts, United States
Patent: 162
Iovance Biotherapeutics, Inc.
New York, United States
Patent: 151
Lentigen Technology, Inc.
Washington, United States
Patent: 117
With the analysis among 787 patents, we discovered top 102 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, NantOmics LLC, KSQ Therapeutics, Inc. are active in this area.
Institut National de la Santé et de la Recherche Médicale
California, United States
Patent: 42
Massachusetts, United States
Patent: 40
Myeloid Therapeutics, Inc.
Massachusetts, United States
Patent: 39
Cytoimmune Therapeutics, Inc.
California, United States
Patent: 38
Hovedstaden, Denmark
Patent: 35
Obsidian Therapeutics, Inc.
Massachusetts, United States
Patent: 28
Checkmate Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 18
Victoria, Australia
Patent: 15
With the analysis among related 8,482 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Immatics Biotechnologies GmbH, Iovance Biotherapeutics, Inc., Memorial Sloan-Kettering Cancer Center take 19.88% of patent filing during this period.
Immatics Biotechnologies GmbH
Baden-Württemberg, Germany
Patent: 1,401
Iovance Biotherapeutics, Inc.
New York, United States
Patent: 151
Memorial Sloan-Kettering Cancer Center
New York, United States
Patent: 134
The Board of Regents of The University of Texas System
Texas, United States
Patent: 131
Lentigen Technology, Inc.
Washington, United States
Patent: 83
Texas, United States
Patent: 83
Regents of the University of California
California, United States
Patent: 81
Department of Health & Human Services
With the analysis among related 8,482 patents in last 5 years, we discover 246 new entrants. Iovance Biotherapeutics, Inc., Shattuck Labs, Inc., Kite Pharma, Inc. are the most active new entrants in this area.
Iovance Biotherapeutics, Inc.
New York, United States
Patent: 151
Texas, United States
Patent: 83
California, United States
Patent: 66
California, United States
Patent: 56
Massachusetts, United States
Patent: 40
Myeloid Therapeutics, Inc.
Massachusetts, United States
Patent: 39
Shenzhou Cell Engineering Co Ltd.
Beijing Shi, China
Patent: 33
Obsidian Therapeutics, Inc.
Massachusetts, United States
Patent: 28
With the analysis among 5,850 patents, we discovered top 237 universities and scientific research institutions by total patent application. Baylor College of Medicine, The Johns Hopkins University, New York University are dominant in this area. They take 14.12% of the total patent filing.
Baylor College of Medicine
Texas, United States
Patent: 168
The Johns Hopkins University
New York, United States
Patent: 86
North Carolina, United States
Patent: 84
Connecticut, United States
Patent: 68
The Scripps Research Institute
California, United States
Patent: 61
The Trustees of Columbia University in The City of New York
New York, United States
Patent: 59
National University of Singapore
Central Region, Singapore
Patent: 58
Washington University in St. Louis
Missouri, United States
Patent: 56
ZURICH, Switzerland
Patent: 56